Filing Details

Accession Number:
0000899243-16-026413
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2016-08-05 16:05:47
Reporting Period:
2015-08-07
Filing Date:
2016-08-05
Accepted Time:
2016-08-05 16:05:47
Original Submission Date:
2015-08-07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1559053 Prothena Corp Plc PRTA () 4/A
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1242880 S Christopher Henney C/O Prothena Biosciences Inc
650 Gateway Boulevard
South San Francisco CA 94080
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares, Par Value $0.01 Per Share Acquisiton 2015-08-07 10,000 $6.65 10,000 No 4 M Direct
Ordinary Shares, Par Value $0.01 Per Share Disposition 2015-08-07 4,400 $62.34 5,600 No 4 S Direct
Ordinary Shares, Par Value $0.01 Per Share Disposition 2015-08-07 4,560 $63.25 1,040 No 4 S Direct
Ordinary Shares, Par Value $0.01 Per Share Disposition 2015-08-07 1,040 $64.03 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Stock Option (right to buy) Disposition 2015-08-07 10,000 $0.00 10,000 $6.65
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
40,000 2023-03-18 No 4 M Direct
Footnotes
  1. The transaction was executed in multiple trades in prices ranging from $61.785 to $62.785, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
  2. The transaction was executed in multiple trades in prices ranging from $62.80 to $63.785, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
  3. The transaction was executed in multiple trades in prices ranging from $63.84 to $64.16, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
  4. The shares subject to the option are fully vested and exercisable as of the date hereof.
  5. In the original Form 4 filed on August 7, 2015, due to an administrative error, the purchase price in column four of row one of Table I was incorrectly listed as $6.41, rather than the correct purchase price of $6.65. This amendment is filed to correct the Form 4 to report the acquisition price of $6.65 per share under the reported transaction.